4,725 Shares in Humana Inc. (NYSE:HUM) Bought by Convergence Investment Partners LLC

Convergence Investment Partners LLC bought a new position in shares of Humana Inc. (NYSE:HUM - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 4,725 shares of the insurance provider's stock, valued at approximately $1,250,000.

A number of other institutional investors have also modified their holdings of the stock. Revolve Wealth Partners LLC bought a new position in shares of Humana during the fourth quarter valued at approximately $202,000. Teacher Retirement System of Texas boosted its stake in shares of Humana by 780.0% during the fourth quarter. Teacher Retirement System of Texas now owns 7,102 shares of the insurance provider's stock valued at $1,802,000 after purchasing an additional 6,295 shares in the last quarter. Mizuho Securities USA LLC boosted its stake in shares of Humana by 46.2% during the fourth quarter. Mizuho Securities USA LLC now owns 11,412 shares of the insurance provider's stock valued at $2,895,000 after purchasing an additional 3,605 shares in the last quarter. American Century Companies Inc. boosted its stake in shares of Humana by 8.8% during the fourth quarter. American Century Companies Inc. now owns 12,655 shares of the insurance provider's stock valued at $3,211,000 after purchasing an additional 1,027 shares in the last quarter. Finally, Sei Investments Co. boosted its stake in shares of Humana by 16.3% during the fourth quarter. Sei Investments Co. now owns 86,472 shares of the insurance provider's stock valued at $21,937,000 after purchasing an additional 12,142 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Up 3.9%

Shares of NYSE:HUM traded up $9.01 during trading hours on Friday, reaching $238.22. The stock had a trading volume of 1,569,145 shares, compared to its average volume of 1,505,668. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $406.09. The firm's 50 day moving average is $234.56 and its 200-day moving average is $256.27. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.91 and a current ratio of 1.91. The stock has a market capitalization of $28.75 billion, a price-to-earnings ratio of 16.85, a P/E/G ratio of 1.57 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.42% and a return on equity of 14.47%. The business had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. During the same quarter in the prior year, the business posted $7.23 EPS. The company's revenue for the quarter was up 8.4% on a year-over-year basis. Research analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on HUM shares. Oppenheimer increased their price objective on shares of Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a research note on Thursday, May 1st. Wall Street Zen upgraded shares of Humana from a "hold" rating to a "buy" rating in a research note on Sunday, July 20th. Robert W. Baird lowered their target price on shares of Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research note on Friday. Truist Financial dropped their price objective on shares of Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a report on Wednesday, July 16th. Finally, Barclays set a $268.00 price target on Humana and gave the stock an "equal weight" rating in a research report on Thursday, June 12th. Sixteen analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $282.43.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.